WuXi Biologics (Cayman) Inc. (WXXWY)
OTCMKTS · Delayed Price · Currency is USD
8.19
+0.09 (1.11%)
Dec 1, 2025, 4:00 PM EST
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of $16.59 billion as of December 2, 2025. Its market cap has increased by 83.58% in one year.
Market Cap
16.59B
Enterprise Value
16.12B
Revenue
2.80B
Ranking
n/a
PE Ratio
28.32
Stock Price
$8.19
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 4.11B to 16.59B, an increase of 303.82%. That is a compound annual growth rate of 17.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 16.77B | 80.67% |
| Dec 31, 2024 | 9.28B | -41.99% |
| Dec 29, 2023 | 16.00B | -50.63% |
| Dec 30, 2022 | 32.41B | -35.36% |
| Dec 31, 2021 | 50.14B | -7.43% |
| Dec 31, 2020 | 54.16B | 230.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 819.20M |
| Elite Pharmaceuticals | 563.95M |
| Glass House Brands | 520.12M |
| CytoDyn | 398.68M |
| American Oncology Network | 363.17M |
| Northwest Biotherapeutics | 359.83M |
| Silence Therapeutics | 311.27M |
| Nika Pharmaceuticals | 259.91M |